Metagenomi, Inc. Common Stock (MGX) — Financial Flexibility Index
Metagenomi, Inc. Common Stock (MGX) has a Financial Flexibility Index of -0.32x as of June 2026. Free cash flow of $-19.39 Million (operating CF $-19.51 Million minus capex $125.00K) represents 0% of total liabilities ($61.13 Million). Check MGX total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Metagenomi, Inc. Common Stock Financial Flexibility Index (2021–2025)
Historical Financial Flexibility Index trend for Metagenomi, Inc. Common Stock across 5 annual periods. For the full cash flow conversion analysis, see MGX cash flow conversion.
Annual Financial Flexibility Index for Metagenomi, Inc. Common Stock (2021–2025)
Year-by-year free cash flow to debt coverage for Metagenomi, Inc. Common Stock. Explore Metagenomi, Inc. Common Stock cash debt coverage ratio to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -1.41x | $-88.32 Million | $-88.89 Million | $62.51 Million | ▼ -19.7% |
| 2024 | -1.18x | $-105.96 Million | $-109.07 Million | $89.74 Million | ▼ -624.1% |
| 2023 | -0.16x | $-81.59 Million | $-91.41 Million | $500.43 Million | ▼ -282.4% |
| 2022 | 0.09x | $43.70 Million | $29.72 Million | $488.91 Million | ▼ -42.6% |
| 2021 | 0.16x | $27.16 Million | $24.26 Million | $174.54 Million | — |